0001209191-14-052238.txt : 20140813 0001209191-14-052238.hdr.sgml : 20140813 20140813174829 ACCESSION NUMBER: 0001209191-14-052238 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140811 FILED AS OF DATE: 20140813 DATE AS OF CHANGE: 20140813 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ROUTE 141 & HENRY CLAY ROAD STREET 2: BUILDING E336 CITY: WILMINGTON STATE: DE ZIP: 19880 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: ROUTE 141 & HENRY CLAY ROAD STREET 2: BUILDING E336 CITY: WILMINGTON STATE: DE ZIP: 19880 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Flannelly Barry P CENTRAL INDEX KEY: 0001615842 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 141038748 MAIL ADDRESS: STREET 1: ROUTE 141 AND HENRY CLAY ROAD CITY: WILMINGTON STATE: DE ZIP: 19880 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-08-11 0 0000879169 INCYTE CORP INCY 0001615842 Flannelly Barry P EXPERIMENTAL STATION ROUTE 141 & HENRY CLAY ROAD WILMINGTON DE 19880 0 1 0 0 See Remarks Incentive Stock Option (right to buy) 48.44 2014-08-11 4 A 0 6192 0.00 A 2021-08-10 Common Stock 6192 6192 D Non-Qualified Stock Options (right to buy) 48.44 2014-08-11 4 A 0 42218 0.00 A 2021-08-10 Common Stock 42218 42218 D Beginning August 11, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. Exec VP, Bus Dev and Strategic Planning /s/ Barry P. Flannelly 2014-08-13